+Vote!
Indy Star (Free subscription) | 9 hours ago
... Abel said. "These are our friends."Keynote speaker Randall Tobias, the former chief executive of Eli Lilly and Co. tapped by President George W. Bush in 2003 to be the U.S. global AIDS coordinator, spoke of successes in recent years but also of the need for more work.Under Bush, Tobias said, the U.S. has led the global fight against AIDS with the President's Emergency Plan for AIDS Relief.Tobias,...
+Vote!
IndyStar.com (Free subscription) | 9 hours ago
... Abel said. "These are our friends."Keynote speaker Randall Tobias, the former chief executive of Eli Lilly and Co. tapped by President George W. Bush in 2003 to be the U.S. global AIDS coordinator, spoke of successes in recent years but also of the need for more work.Under Bush, Tobias said, the U.S. has led the global fight against AIDS with the President's Emergency Plan for AIDS Relief.Tobias,...
+Vote!
Indy Star (Free subscription) | 29/11/2008
Drug maker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.
+Vote!
News & Observer (Free subscription) | 29/11/2008
Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.
+Vote!
StarTribune.com (Free subscription) | 28/11/2008
Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.
+Vote!
Seattle Times (Free subscription) | 28/11/2008
Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.
+Vote!
San Fransisco Chronicle (Free subscription) | 28/11/2008
Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009. Eli Lilly had filed a supplemental new drug application, asking the Food...
+Vote!
Reuters (Free subscription) | 28/11/2008
CHICAGO (Reuters) - Eli Lilly and Co said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions about the drug's effectiveness and dosing.
+Vote!
Miami Herald (Free subscription) | 28/11/2008
Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.
+Vote!
Seattle Post-Intelligencer (Free subscription) | 28/11/2008
INDIANAPOLIS -- Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.
+Vote!
Indy Star (Free subscription) | 30/11/2008
Roche Diagnostics,which makes diagnostics kits for diabetes, HIV and other ailments, said last month it would cut more than 300 jobs from its Northeastside campus. Pharmaceutical giant Eli Lilly and Co. has been trimming hundreds of Indiana jobs in recent months, bringing its statewide total to less than 12,000. Zimmer Holdings, a Warsaw maker of knee and hip implants, is losing market share...
+Vote!
Indy Star (Free subscription) | 29/11/2008
Westfield » An 82-year-old retired chemist died Friday afternoon in a fire in his residence, according to WTHR (Channel 13), The Indianapolis Star's newsgathering partner.The man was identified as Raymond Ovelgonne, who was retired from Eli Lilly and Co.An off-duty firefighter reportedly smelled smoke while driving by Ovelgonne's residence along Gray Road in a rural area of Westfield and alerted...
+Vote!
IndyStar.com (Free subscription) | 29/11/2008
Westfield » An 82-year-old retired chemist died Friday afternoon in a fire in his residence, according to WTHR (Channel 13), The Indianapolis Star's newsgathering partner.The man was identified as Raymond Ovelgonne, who was retired from Eli Lilly and Co.An off-duty firefighter reportedly smelled smoke while driving by Ovelgonne's residence along Gray Road in a rural area of Westfield and alerted...
+Vote!
Indy Star (Free subscription) | 28/11/2008
Cymbalta, one of the top-selling drugs for Eli Lilly and Co., already is used as a treatment for depression, general anxiety, nerve damage from diabetes and, most recently, for fibromyalgia.Lilly now sees it potentially aiding people with chronic arthritis-caused knee pain.The Indianapolis-based drugmaker today said it withdrew an application to FDA to use Cymbalta for a broader range of pains...
+Vote!
Market Watch (Free subscription) | 24/11/2008
SAN FRANCISCO (MarketWatch) -- Fitch Ratings on Monday lowered Eli Lilly and Co.'s issuer default rating to A+ from AA and its short-term IDR to F1 from F1+. The downgrade is due to the the incremental debt needed to complete $6.5-billion buyout of ImClone Systems . "Fitch believes that the increased leverage heightens the sensitivity of Eli Lilly's credit profile while the company encounters...
